Firstly, 5,457 immune cells achieved from the tumor-bearing (MC38 cells) mice before and after anti-PD-1/TIM3 treatment were well divided into nine cell subtypes (Figure 7D). The gene discussed is HAVCR2; the disease is neoplasm.